These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1227883)

  • 21. [Effect of tranquilizers (diazepam and chlordiazepoxide) on the blood supply and activity of the heart].
    Chichikanov GG
    Farmakol Toksikol; 1975; 38(3):303-7. PubMed ID: 1227903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental studies with a new radiation protective agent].
    Szirmai E; Berkada B; Hajdukovic S; López-González JM
    Arzneimittelforschung; 1968 May; 18(5):625-8. PubMed ID: 4387834
    [No Abstract]   [Full Text] [Related]  

  • 23. A new potentially antianginal benzofuran with an amiodarone-like pharmacological profile.
    Charlier R; Bauthier J
    Arzneimittelforschung; 1973 Sep; 23(9):1305-11. PubMed ID: 4801226
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological properties of Craviten (M-71).
    Maj J; Kulig D; Myśliwiec D; Bugielska Z; Tomsa E; Zaczyńska-Kostrakiewicz M
    Pol J Pharmacol Pharm; 1980; 32(6):855-75. PubMed ID: 7243682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: Pharmacological effects of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (BL 191).
    Sakurai M; Kitatani T; Nagato K; Sakaguchi T
    Jpn J Pharmacol; 1974; 24(0):s:68. PubMed ID: 4546078
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: Review of the cardiovascular pharmacology of perhexiline.
    Hudak WJ; Lewis RE; Lucas RW; Kuhn WL
    Postgrad Med J; 1973 Apr; 49():Suppl 3:16-25. PubMed ID: 4202743
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacology of Go-1002.
    Grewal RS; Kaul CL; David J
    J Pharmacol Exp Ther; 1968 Apr; 160(2):268-76. PubMed ID: 4384786
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nonachlasine--a new drug for treatment of ischemic heart disease].
    Kaverina NV; Markova GA; Chichkanov GG; Chumburidze VB; Basaeva AI
    Kardiologiia; 1975 Jul; 15(7):43-8. PubMed ID: 1569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative analysis of the action of 2 calmodulin inhibitors on the contractile function of the isolated heart].
    Kapel'ko VI; Novikova NA
    Fiziol Zh SSSR Im I M Sechenova; 1985 Sep; 71(9):1095-100. PubMed ID: 4054393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of fomocaine on heart and circulation (author's transl)].
    Reuter N; Meyer F; Ziegenmeyer J; Bock M
    Arzneimittelforschung; 1975; 25(12):1900-6. PubMed ID: 1243660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacology of ethacizin].
    Kaverina NV; Skoldinov AP; Senova ZP; Gritsenko AN; Lyskovtsev VV
    Farmakol Toksikol; 1985; 48(5):43-9. PubMed ID: 3908141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.
    Kochiadakis GE; Skalidis EI; Kalebubas MD; Igoumenidis NE; Chrysostomakis SI; Kanoupakis EM; Simantirakis EN; Vardas PE
    Eur Heart J; 2002 May; 23(9):734-41. PubMed ID: 11978000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological properties of some benzofuran derivatives].
    Stoliarchuk AA; Ivanova NI; Shadurskiĭ KS; Grinev AN; Trofimov FA; Mukhanova TI
    Farmakol Toksikol; 1970; 33(3):292-5. PubMed ID: 4393831
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of purified endogenous inhibitor of the Na+/Ca2+ exchanger on ouabain-induced arrhythmias in the atria and ventricle strips of guinea pig.
    Shpak B; Gofman Y; Shpak C; Hiller R; Boyman L; Khananshvili D
    Eur J Pharmacol; 2006 Dec; 553(1-3):196-204. PubMed ID: 17078946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of nonachlazine on the cardiac component of baroreceptor reflexes in unanesthetized cats].
    Medvedev OS; Stepochkina NA; Matsievskiĭ DD
    Biull Eksp Biol Med; 1980 Sep; 90(9):309-11. PubMed ID: 7426732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of nonachlazine on ino- and chronotropic function].
    Rozonov IuB; Chumburidze VB
    Farmakol Toksikol; 1980; 43(5):575-9. PubMed ID: 7449987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-arrhythmic properties of ethmosine (clinico-experimental study)].
    Kaverina NV; Senova ZP; Lyskovtsev VV
    Kardiologiia; 1978 Apr; 18(4):67-72. PubMed ID: 671970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of nonachlazine on systemic hemodynamics and the collateral coronary circulation in acute myocardial ischemia].
    Pilipchuk DB; Berger DIa; Sapozhkov AV
    Farmakol Toksikol; 1980; 43(3):324-7. PubMed ID: 7449970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of amezinium, a novel antihypotensive drug. II. Examination of cardiovascular effects.
    Lehmann HD; Giertz H; Kretzschmar R; Lenke D; von Philipsborn G; Raschack M; Schuster J
    Arzneimittelforschung; 1981; 31(9a):1544-57. PubMed ID: 7197969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.